{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:50:37Z","timestamp":1782427837003,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"am","delay-in-days":354,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI134971"],"award-info":[{"award-number":["R01AI134971"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2UC4DK098085"],"award-info":[{"award-number":["2UC4DK098085"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD021831"],"award-info":[{"award-number":["S10OD021831"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"DFG","doi-asserted-by":"publisher","award":["PF 937\/1-1"],"award-info":[{"award-number":["PF 937\/1-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.clim.2022.109076","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T12:49:59Z","timestamp":1657284599000},"page":"109076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effect of IL4 and IL10 on a human in vitro type 1 diabetes model"],"prefix":"10.1016","volume":"241","author":[{"given":"Susanne E.M.","family":"Pfeiffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estefania","family":"Quesada-Masachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burcak","family":"Yesildag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zbigniew","family":"Mikulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"von Herrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2022.109076_bb0005","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.4049\/jimmunol.162.5.2511","article-title":"Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes","volume":"162","author":"Bradley","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0010","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1084\/jem.184.3.1093","article-title":"Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice","volume":"184","author":"Mueller","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109076_bb0015","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1084\/jem.178.1.87","article-title":"Interleukln 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice","volume":"178","author":"Rapoport","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109076_bb0020","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2249.2007.03375.x","article-title":"Pre-incubation with interleukin-4 mediates a direct protective effect against the loss of pancreatic \u03b2-cell viability induced by proinflammatory cytokines","volume":"148","author":"Kaminski","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-018-4750-8","article-title":"The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes","volume":"62","author":"Leslie","year":"2019","journal-title":"Diabetologia."},{"key":"10.1016\/j.clim.2022.109076_bb0030","doi-asserted-by":"crossref","first-page":"894","DOI":"10.4049\/jimmunol.1700410","article-title":"On the role IL-4\/IL-13 Heteroreceptor plays in regulation of type 1 diabetes","volume":"199","author":"Ukah","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108394","article-title":"IL-4R is expressed on alpha and beta cells of human pancreata","volume":"214","author":"Rajendran","year":"2020","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0040","doi-asserted-by":"crossref","first-page":"4507","DOI":"10.4049\/jimmunol.158.9.4507","article-title":"A noncytolytic IL-10\/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice","volume":"158","author":"Zheng","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clin.1994.1068","article-title":"Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse","volume":"71","author":"Pennline","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2022.109076_bb0050","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.1073\/pnas.251532298","article-title":"Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice","volume":"98","author":"Goudy","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2022.109076_bb0055","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11010-010-0539-x","article-title":"Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine","volume":"344","author":"Xu","year":"2010","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.clim.2022.109076_bb0060","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/intimm\/6.12.1927","article-title":"Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice","volume":"6","author":"Moritani","year":"1994","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0065","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/00007890-199710150-00017","article-title":"Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice","volume":"64","author":"Smith","year":"1997","journal-title":"Transplantation."},{"key":"10.1016\/j.clim.2022.109076_bb0070","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.2337\/diabetes.48.10.1948","article-title":"T-cell production of an inducible interleukin-10 transgene provides limited protection from autoimmune diabetes","volume":"48","author":"Pauza","year":"1999","journal-title":"Diabetes."},{"key":"10.1016\/j.clim.2022.109076_bb0075","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","article-title":"Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes","volume":"59","author":"Richardson","year":"2016","journal-title":"Diabetologia."},{"key":"10.1016\/j.clim.2022.109076_bb0080","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/IR:23:2-3:179","article-title":"IL-4 signaling, gene transcription regulation, and the control of effector T cells","volume":"23","author":"Boothby","year":"2001","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2022.109076_bb0085","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12026-011-8205-2","article-title":"Transcriptional regulation by STAT6","volume":"50","author":"Goenka","year":"2011","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2022.109076_bb0090","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.4049\/jimmunol.180.9.5771","article-title":"IL-10: the master regulator of immunity to infection","volume":"180","author":"Couper","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0095","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/19382014.2014.950547","article-title":"The impact of anti-inflammatory cytokines on the pancreatic \u03b2-cell","volume":"6","author":"Russell","year":"2014","journal-title":"Islets."},{"key":"10.1016\/j.clim.2022.109076_bb0105","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00125-016-4201-3","article-title":"Interferon-\u03b1 mediates human beta cell HLA class I overexpression, endoplasmic reticulum stress and apoptosis, three hallmarks of early human type 1 diabetes","volume":"60","author":"Marroqui","year":"2017","journal-title":"Diabetologia."},{"key":"10.1016\/j.clim.2022.109076_bb0110","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1210\/jcem.86.10.7938","article-title":"Th2 cytokines have a partial, direct protective effect on the function and survival of isolated human islets exposed to combined proinflammatory and Th1 cytokines","volume":"86","author":"Marselli","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.clim.2022.109076_bb0115","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.181.2.537","article-title":"Stimulatory and inhibitory effects of interleukin (IL) -4 and ID13 on the production of cytokines by human peripheral blood mononuclear cells\u202f: priming for ID12 and tumor necrosis factor c ~ production","volume":"181","author":"D\u2019Andrea","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2022.109076_bb0120","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/intimm\/4.5.563","article-title":"Differential effects of IL-4 and IL-10 on IL-2-induced IFN-7 synthesis and lymphokine-activated killer activity","volume":"4","author":"Hsu","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0125","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1002\/eji.200838334","article-title":"IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit","volume":"38","author":"Sasaki","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2022.109076_bb0130","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1097\/TP.0b013e318188ab04","article-title":"Hydrogen peroxide-induced VCAM-1 expression in pancreatic islets and \u03b2-cells through extracellular Ca2+ influx","volume":"86","author":"Lee","year":"2008","journal-title":"Transplantation."},{"key":"10.1016\/j.clim.2022.109076_bb0135","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00125-021-05619-9","article-title":"Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes","volume":"65","author":"Quesada-Masachs","year":"2022","journal-title":"Diabetologia."},{"key":"10.1016\/j.clim.2022.109076_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102628","article-title":"HLA class I hyper-expression unmasks beta cells but not alpha cells to the immune system in pre-diabetes","volume":"119","author":"Benkahla","year":"2021","journal-title":"J. Autoimmun."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001577?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661622001577?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:02:56Z","timestamp":1778616176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661622001577"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":28,"alternative-id":["S1521661622001577"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2022.109076","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of IL4 and IL10 on a human in vitro type 1 diabetes model","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2022.109076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109076"}}